Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 10/20 | 0.49 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.49 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.49 |
| ▸ | FPR1 | P21462 | 1/20 | 0.49 |
| ▸ | FPR3 | P25089 | 1/20 | 0.49 |
| ▸ | GPR183 | P32249 | 1/20 | 0.49 |
| ▸ | APLNR | P35414 | 1/20 | 0.49 |
| ▸ | GPR65 | Q8IYL9 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | GRM5 | P41594 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.42 |
| ▸ | IKBKB | O14920 | 1/20 | 0.39 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.39 |
| ▸ | FEN1 | P39748 | 1/20 | 0.39 |
| ▸ | VCP | P55072 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30231559 | 1.00 | FFAR1 (0.49) | FFAR1FFAR4CHRM2S1PR1FPR1 | |
| SCHEMBL30772315 | 0.84 | HSP90AA1 (0.48) | FFAR1TSHRHSP90AA1NTSR1VCP | |
| SCHEMBL12430910 | 0.83 | FFAR1 (0.45) | FFAR1FFAR4CHRM2S1PR1FPR1 | |
| SCHEMBL27167218 | 0.82 | HSP90AA1 (0.64) | FFAR1FFAR4CHRM2S1PR1FPR1 | |
| SCHEMBL11572436 | 0.82 | IKBKB (0.44) | FFAR1FFAR4CHRM2S1PR1FPR1 | |
| SCHEMBL6563215 | 0.79 | FFAR1 (0.42) | FFAR1FFAR4CHRM2S1PR1FPR1 | |
| SCHEMBL15841077 | 0.79 | FFAR1 (0.45) | FFAR1FFAR4CHRM2S1PR1FPR1 | |
| SCHEMBL6329854 | 0.77 | FFAR1 (0.44) | FFAR1FFAR4CHRM2S1PR1FPR1 | |
| SCHEMBL17407733 | 0.77 | CYP1A2 (0.46) | FFAR1FFAR4CHRM2S1PR1FPR1 | |
| SCHEMBL25229437 | 0.77 | FFAR1 (0.47) | FFAR1ERCC5FEN1VCPNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8822628-B2 | Crosslinkable liquid crystalline polymer | TICONA LLC (US) | 2014-09-02 | — | — | US | claimed |
| US-20140088285-A1 | Crosslinkable Liquid Crystalline Polymer | TICONA LLC (US) | 2014-03-27 | — | — | US | claimed |
| CN-1183133-C | 2-amino-6-anilino-purines and their use as medicaments | ��˹��ŵ�� | 2005-01-05 | — | — | CN | claimed |
| CN-1340054-A | 2-amino-6-anilino-purines and their use as medicaments | NOVARTIS AG (CH) | 2002-03-13 | — | — | CN | claimed |
| WO-2023114539-A1 | AMINO CHROMEN-2-ONE MODULATORS OF POLRMT | PRETZEL THERAPEUTICS, INC. (US) | 2023-06-22 | — | — | WO | disclosed |
| CN-110498773-B | Method for synthesizing 1, 4-substituted 1,2, 3-triazole from acetylenic acid | 乐山师范学院 | 2021-07-02 | — | — | CN | disclosed |
| CN-107556269-B | Synthetic method of alpha-alkynyl substituted ether compound | 南京理工大学 | 2020-11-06 | — | — | CN | disclosed |
| US-20170267824-A1 | PREPREG COMPOSITE CONTAINING A CROSSLINKED AROMATIC POLYESTER | TICONA LLC | 2017-09-21 | — | — | US | disclosed |
| EP-2606025-B1 | PROCESS FOR PREPARING A PROPIOLIC ACID OR A DERIVATIVE THEREOF | BASF SE (DE) | 2016-10-12 | — | — | EP | disclosed |
| US-20150274886-A1 | Crosslinkable Soluble Aromatic Polyester | TICONA LLC | 2015-10-01 | — | — | US | disclosed |
| US-9145519-B2 | Crosslinkable aromatic polyester | TICONA LLC (US) | 2015-09-29 | — | — | US | disclosed |
| US-9073844-B2 | Process for preparing a propiolic acid or a derivative thereof | BASF SE (DE) | 2015-07-07 | — | — | US | disclosed |
| EP-1224189-B1 | CONDENSED DIHYDROQUINOLINONE DERIVATIVES FOR INHIBITING MRP1 | LILLY CO ELI (US) | 2006-01-25 | — | — | EP | disclosed |
| CN-1183133-C | 2-amino-6-anilino-purines and their use as medicaments | ��˹��ŵ�� | 2005-01-05 | — | — | CN | disclosed |
| US-20040077675-A1 | Compounds and methods for inhibiting MRP1 | BONJOUKLIAN ROSANNE (US) | 2004-04-22 | — | — | US | disclosed |
| US-6670373-B1 | Inhibiting resistant neoplasms where the resistance is conferred by multidrug resistance protein; N-3,4,5-trimethoxyphenyl-3-(3-azidomethyl-isoxazolo(4,5-c) -1,2-dihydro-6-chloro-quinolin-2-on-1-yl)phenylacetamide | ELI LILLY AND COMPANY | 2003-12-30 | — | — | US | disclosed |
| EP-1224189-A2 | CONDENSED DIHYDROQUINOLINONE DERIVATIVES FOR INHIBITING MRP1 | ELI LILLY AND COMPANY (US) | 2002-07-24 | — | — | EP | disclosed |
| CN-1340054-A | 2-amino-6-anilino-purines and their use as medicaments | NOVARTIS AG (CH) | 2002-03-13 | — | — | CN | disclosed |
| WO-2001027116-A2 | CONDENSED DIHYDROQUINOLINONE DERIVATIVES FOR INHIBITING MRP1 | ELI LILLY AND COMPANY (US) | 2001-04-19 | — | — | WO | disclosed |
| US-4647526-A | Heat-developable light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1987-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077675-A1 | Compounds and methods for inhibiting MRP1 | ABCC1, ABCB1, ABCB11 | FFAR1 4492/4885FFAR4 4848/4885CHRM2 4808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.